{"entity":{"type":"insider","cik":"0001600253","url":"/insider/0001600253","json_url":"/insider/0001600253.json","name":"Crotty Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2015-02-18","last":"2019-08-26","span_basis":"filed_date"},"name_variants":[{"name":"Crotty Robert","source":"filing","n_filings":3,"first_seen":"2015-02-18","last_seen":"2019-08-26"}],"transactions":[{"id":9223462,"accession":"0001104659-19-047349","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-047349","line_url":"/filing/0001104659-19-047349#line-1","is_derivative":false,"issuer_cik":"0001600253","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001600253","owner_cik":"0001600253","owner_name":"Crotty Robert","owner_url":"/insider/0001600253","role":"Officer (Gen Counsel & Corp Secretary)","officer_title":"Gen Counsel & Corp Secretary","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3797.0,"shares_display":"3,797","price_per_share":2.08,"price_display":"2.08","price_state":"stated","total_value":7897.76,"total_display":"7,897.76","shares_owned_after":23239.0,"shares_owned_after_display":"23,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-26","scope":"insider"},{"id":6183502,"accession":"0001104659-18-035359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-035359","line_url":"/filing/0001104659-18-035359#line-1","is_derivative":false,"issuer_cik":"0001600253","issuer_name":"Nabriva Therapeutics plc","issuer_ticker":"NBRV","issuer_name_source":null,"issuer_url":"/issuer/0001600253","owner_cik":"0001600253","owner_name":"Crotty Robert","owner_url":"/insider/0001600253","role":"Officer (General Counsel & Secretary)","officer_title":"General Counsel & Secretary","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.48,"price_display":"4.48","price_state":"stated","total_value":44800.0,"total_display":"44,800.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-23","filed_date":"2018-05-23","scope":"insider"},{"id":8573627,"accession":"0001209191-15-015679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-015679","line_url":"/filing/0001209191-15-015679#line-1","is_derivative":false,"issuer_cik":"0001107332","issuer_name":"DENDREON CORP","issuer_ticker":"DNDNQ","issuer_name_source":null,"issuer_url":"/issuer/0001107332","owner_cik":"0001600253","owner_name":"Crotty Robert","owner_url":"/insider/0001600253","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21764.0,"shares_display":"21,764","price_per_share":0.0811,"price_display":"0.08","price_state":"stated","total_value":1765.0604,"total_display":"1,765.06","shares_owned_after":97855.0,"shares_owned_after_display":"97,855","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001641640","name":"Nabriva Therapeutics plc","url":"/issuer/0001641640","role":"Officer (Gen Counsel & Corp Secretary)","n_filings":2,"first_seen":"2018-05-23","last_seen":"2019-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001107332","name":"DENDREON CORP","url":"/issuer/0001107332","role":"Officer (EVP, General Counsel)","n_filings":1,"first_seen":"2015-02-18","last_seen":"2015-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001600253","retrieved_at":"2026-08-21T16:29:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}